ArticleFrontiers in cellular and infection microbiology2026
The incremental value of a novel immuno-inflammatory index (SIICI) in predicting sepsis after ureteroscopic lithotripsy: development and validation of a nomogram.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sepsis continues to be a life-threatening complication following ureteroscopic lithotripsy (URSL). Available clinical prediction tools tend to be inadequate in their capacity to depict the underlying pathophysiology of sepsis-systemic immune-inflammatory imbalance. It is particularly difficult in patients who lack obvious preoperative microbiological findings. The study aims to evaluate the new Systemic Immune-Inflammatory Complex Index (SIICI) as well as other indices such as (SII, SIRI, PIV) in predicting post-URSL sepsis. Methods: We performed a single-center retrospective study of 803 patients who underwent URSL. Multivariate logistic regression was used to create a clinical baseline model. To assess the incremental predictive value, each inflammatory index was added separately to the baseline model. The model performance was compared using the area under the ROC curve (AUC), net reclassification improvement (NRI), integrated discrimination improvement (IDI), likelihood ratio test (LRT) and decision curve analysis (DCA). Results: The "Base + SIICI" model was found to be the most effective among the four indices. It had the highest degree of discrimination (AUC = 0.863, 95% CI: 0.819-0.908), which is a considerable improvement over the baseline model (AUC = 0.807, p<0.001). There were meaningful improvements in reclassification (NRI = 0.133, p=0.001) and discrimination (IDI = 0.058, p=0.002), a significant likelihood ratio test (p<0.001) backed up these findings. The decision curve analysis confirmed that higher net clinical benefit was found at a larger variety of probability thresholds. Notably, the model performed well in individuals with negative preoperative urine cultures (AUC = 0.850). A visual nomogram was developed and validated based on this model, showing good calibration and a bootstrap-corrected AUC of 0.849. An online calculator was also created to facilitate clinical application. Conclusion: SIICI is a new index that offers high incremental value in predicting sepsis after URSL compared to traditional indices like SII, SIRI and PIV. Nomogram based on SIICI presents a strong and useful instrument of early stratification of risks of development and can assist in making proactive clinical decisions, particularly where standard infection indicators cannot be used.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.